Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H20O5S |
Molecular Weight | 336.403 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=CC=C(C=C2C=C1)[C@H](C)C(=O)OCCS(C)(=O)=O
InChI
InChIKey=JGBUBSOKFSVXKS-LBPRGKRZSA-N
InChI=1S/C17H20O5S/c1-12(17(18)22-8-9-23(3,19)20)13-4-5-15-11-16(21-2)7-6-14(15)10-13/h4-7,10-12H,8-9H2,1-3H3/t12-/m0/s1
Naproxen etemesil is a lipophilic, non-acidic, inactive prodrug of the non-steroidal anti-inflammatory drug (NSAID) naproxen that is hydrolysed to pharmacologically active naproxen once absorbed. Naproxen etemesil was in development with Logical Therapeutics for the treatment of osteoarthritis. However, no recent development has been reported. It is also in phase I clinical trials for the treatment of inflammation and arthritis.The compound was originally developed by Medinox, licensed to Logical Therapeutics in 2006 for partial rights.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20804454
A multicentre, randomized, double-blind, double-dummy trial compared oral naproxen etemesil 1200 mg twice daily (n = 61) with naproxen 500 mg twice daily (n = 59) for 7.5 days in 120 healthy subjects
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB12398
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
25170420
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
214269U36R
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
SUB127210
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
100000153206
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
DTXSID60191903
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
385800-16-8
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
CHEMBL2105683
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
C166529
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY | |||
|
WW-75
Created by
admin on Fri Dec 15 17:32:00 UTC 2023 , Edited by admin on Fri Dec 15 17:32:00 UTC 2023
|
PRIMARY |
SUBSTANCE RECORD